These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 15691639

  • 41. A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study.
    Kalofonos HP, Bamias A, Koutras A, Papakostas P, Basdanis G, Samantas E, Karina M, Misailidou D, Pisanidis N, Pentheroudakis G, Economopoulos T, Papadimitriou C, Skarlos DV, Pectasides D, Stavropoulos M, Bafaloukos D, Kardamakis D, Karanikiotis C, Vourli G, Fountzilas G, Hellenic Cooperative Oncology Group Study.
    Eur J Cancer; 2008 Aug; 44(12):1693-700. PubMed ID: 18639450
    [Abstract] [Full Text] [Related]

  • 42. Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma.
    Schmidt J, Abel U, Debus J, Harig S, Hoffmann K, Herrmann T, Bartsch D, Klein J, Mansmann U, Jäger D, Capussotti L, Kunz R, Büchler MW.
    J Clin Oncol; 2012 Nov 20; 30(33):4077-83. PubMed ID: 23008325
    [Abstract] [Full Text] [Related]

  • 43. Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
    Carlomagno C, Lauria R, De Laurentiis M, Arpino G, Massarelli E, Ferrara C, Milano A, Vernaglia Lombardi A, Costanzo R, Catalano G, Bianco AR, De Placido S.
    Oncology; 2002 Nov 20; 63(3):219-25. PubMed ID: 12381900
    [Abstract] [Full Text] [Related]

  • 44. 5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial.
    Tsavaris NB, Tentas K, Kosmidis P, Mylonakis N, Sakelaropoulos N, Kosmas C, Lisaios B, Soumilas A, Mandrekois D, Tsetis A, Klonaris C.
    Am J Clin Oncol; 1996 Oct 20; 19(5):517-21. PubMed ID: 8823483
    [Abstract] [Full Text] [Related]

  • 45. Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14).
    Lee CK, Chon HJ, Cheon J, Lee MA, Im HS, Jang JS, Kim MH, Park S, Kang B, Hong M, Kim JW, Park HS, Kang MJ, Park YN, Choi HJ.
    Lancet Gastroenterol Hepatol; 2023 Jan 20; 8(1):56-65. PubMed ID: 36328033
    [Abstract] [Full Text] [Related]

  • 46. Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. ONCOPAZ Cooperative Group, Spain.
    Feliu J, González Barón M, García Girón C, Espinosa E, Vicent JM, Gómez Navarro J, Berrocal A, Ordóñez A, Vilches Y, de Castro J, Díaz J.
    Am J Clin Oncol; 1996 Dec 20; 19(6):577-80. PubMed ID: 8931675
    [Abstract] [Full Text] [Related]

  • 47. Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.
    Patt YZ, Hassan MM, Lozano RD, Waugh KA, Hoque AM, Frome AI, Lahoti S, Ellis L, Vauthey JN, Curley SA, Schnirer II, Raijman I.
    Clin Cancer Res; 2001 Nov 20; 7(11):3375-80. PubMed ID: 11705850
    [Abstract] [Full Text] [Related]

  • 48. 5-Fluorouracil plus interferon alpha-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: a multicentric randomized study.
    Palmeri S, Meli M, Danova M, Bernardo G, Leonardi V, Dastoli G, Rausa L, Russo A, Filippelli G, Palmieri G, Russo A, Della Vittoria Scarpati M, Lo Russo V, Di Lauro L, Colucci G, Bruni G, Piazzi M, Gebbia N, Spada S.
    J Cancer Res Clin Oncol; 1998 Nov 20; 124(3-4):191-8. PubMed ID: 9619746
    [Abstract] [Full Text] [Related]

  • 49. Randomized trial of 5-fluorouracil and high-dose folinic acid with or without alpha-2B interferon in advanced colorectal cancer.
    Recchia F, Nuzzo A, Lalli A, Lombardo M, Di Lullo L, Fabiani F, Fanini R, Venturoni L, Torchio P, Peretti G.
    Am J Clin Oncol; 1996 Jun 20; 19(3):301-4. PubMed ID: 8638546
    [Abstract] [Full Text] [Related]

  • 50. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators.
    Lancet; 1995 Apr 15; 345(8955):939-44. PubMed ID: 7715291
    [Abstract] [Full Text] [Related]

  • 51. Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma.
    Taïeb J, Mitry E, Boige V, Artru P, Ezenfis J, Lecomte T, Clavero-Fabri MC, Vaillant JN, Rougier P, Ducreux M.
    Ann Oncol; 2002 Aug 15; 13(8):1192-6. PubMed ID: 12181241
    [Abstract] [Full Text] [Related]

  • 52. Use of high-dose cytarabine to enhance cisplatin cytotoxicity-effects on the response and overall survival rates of advanced head and neck cancer patients.
    Jelić S, Stamatović Lj, Vucićević S, Petrović Z, Kreacić M, Babović N, Jovanović N, Mikić A, Gavrilović D.
    Eur J Cancer; 2002 Jul 15; 38(11):1478-89. PubMed ID: 12110494
    [Abstract] [Full Text] [Related]

  • 53. Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial.
    Belkouz A, de Vos-Geelen J, Mathôt RAA, Eskens FALM, van Gulik TM, van Oijen MGH, Punt CJA, Wilmink JW, Klümpen HJ.
    Br J Cancer; 2020 Mar 15; 122(5):634-639. PubMed ID: 31919404
    [Abstract] [Full Text] [Related]

  • 54. Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract.
    Wadler S, Damle S, Haynes H, Kaleya R, Schechner R, Berkenblit R, Ladner RD, Murgo A.
    J Clin Oncol; 1999 Jun 15; 17(6):1771-8. PubMed ID: 10561214
    [Abstract] [Full Text] [Related]

  • 55. Retrospective comparative analysis of 5FU + low-dose folinic acid vs. 5FU + high-dose folinic acid in the treatment of metastatic colorectal cancer. The Ottawa experience.
    Maroun JA, Cripps C, Goel R, Dahrouge S, Boisvert D.
    Am J Clin Oncol; 1997 Aug 15; 20(4):387-92. PubMed ID: 9256896
    [Abstract] [Full Text] [Related]

  • 56. A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma.
    Ducreux M, Rougier P, Pignon JP, Douillard JY, Seitz JF, Bugat R, Bosset JF, Merouche Y, Raoul JL, Ychou M, Adenis A, Berthault-Cvitkovic F, Luboinski M, Groupe Digestif of the Fédération Nationale des Centres de Lutte Contre le Cancer Digestif.
    Ann Oncol; 2002 Aug 15; 13(8):1185-91. PubMed ID: 12181240
    [Abstract] [Full Text] [Related]

  • 57. Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.
    Cascinu S, Labianca R, Alessandroni P, Marcellini M, Silva RR, Pancera G, Testa E, Martignoni G, Barni S, Frontini L, Zaniboni A, Luporini G, Cellerino R, Catalano G.
    J Clin Oncol; 1997 Nov 15; 15(11):3313-9. PubMed ID: 9363860
    [Abstract] [Full Text] [Related]

  • 58. Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancer.
    Fine S, Erlichman C, Kaizer L, Warr D, Gadalla T.
    Breast Cancer Res Treat; 1994 Nov 15; 30(2):205-9. PubMed ID: 7949219
    [Abstract] [Full Text] [Related]

  • 59. Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Fédération Francophone de Cancérologie Digestive 9902 phase II randomised study.
    Phelip JM, Vendrely V, Rostain F, Subtil F, Jouve JL, Gasmi M, Michel P, Le Malicot K, Smith D, Seitz JF, Fauchart JP, Martin P, Bennouna J, Morin T, Bonnet I, Maingon P, Lepage C, Chauffert B.
    Eur J Cancer; 2014 Nov 15; 50(17):2975-82. PubMed ID: 25241229
    [Abstract] [Full Text] [Related]

  • 60. A randomized clinical trial with a weekly regimen of 5-fluorouracil with or without folinic acid in advanced gastrointestinal adenocarcinomas: a preliminary report.
    Martoni A, Cricca A, Guaraldi M, Farris A, Pannuti F.
    J Chemother; 1989 Jun 15; 1(3):197-202. PubMed ID: 2677260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.